Corrigendum: The prognosis value of CONUT and SIS score for recurrent or metastatic esophageal squamous cell carcinoma patients treated with second-line immunotherapy

Xiao-Han Zhao; Wen-Bin Shen; Duo Wang; He-Song Wang; Chun-Yang Song; Wen-Zhao Deng

doi:10.3389/fonc.2023.1347301

Corrigendum: The prognosis value of CONUT and SIS score for recurrent or metastatic esophageal squamous cell carcinoma patients treated with second-line immunotherapy

Front Oncol. 2023 Dec 12:13:1347301. doi: 10.3389/fonc.2023.1347301. eCollection 2023.

Authors

Xiao-Han Zhao¹, Wen-Bin Shen¹, Duo Wang², He-Song Wang¹, Chun-Yang Song¹, Wen-Zhao Deng¹

Affiliations

¹ Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
² Hebei Key Laboratory of Animal Physiology, Biochemistry and Molecular Biology, College of Life Sciences, Hebei Normal University, Shijiazhuang, China.

Abstract

[This corrects the article DOI: 10.3389/fonc.2023.1167625.].

Keywords: controlling nutritional status; esophageal squamous cell carcinoma; immune checkpoint inhibitors; prognosis; second-line treatment; systemic inflammation score.

Publication types

Published Erratum